483 AstraZeneca Pharmaceuticals LP Oct 2011

483 AstraZeneca Pharmaceuticals LP Oct 2011

Larry Austin FDA, Ifueko Osemwota FDA, Sanket Patel FDA$119.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals LP - Mount Vernon, IN, United States facility and issued inspectional observations (via FDA 483) on 28 Oct 2011.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Oct 2011
  • Location: Mount Vernon, United States
  • FEI: 1825662
Add To Cart